Translate

Vascular Grafts - Medical Devices Pipeline Assessment, 2017

"Vascular Grafts - Medical Devices Pipeline Assessment, 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

Summary

GlobalData's Medical Devices sector report, Vascular Grafts - Medical Devices Pipeline Assessment, 2017" provides an overview of Vascular Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vascular Grafts pipeline products.


This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Scope

- Extensive coverage of the Vascular Grafts under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Vascular Grafts under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Vascular Grafts Overview 7
3 Products under Development 8
3.1 Vascular Grafts - Pipeline Products by Stage of Development 8
3.2 Vascular Grafts - Pipeline Products by Segment 9
3.3 Vascular Grafts - Pipeline Products by Territory 10
3.4 Vascular Grafts - Pipeline Products by Regulatory Path 11
3.5 Vascular Grafts - Pipeline Products by Estimated Approval Date 12
3.6 Vascular Grafts - Ongoing Clinical Trials 13
4 Vascular Grafts - Pipeline Products under Development by Companies 14
4.1 Vascular Grafts Companies - Pipeline Products by Stage of Development 14
4.2 Vascular Grafts - Pipeline Products by Stage of Development 16
5 Vascular Grafts Companies and Product Overview 17
5.1 3S BioMedical, Inc. Company Overview 17
5.1.1 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Ariste Medical LLC Company Overview 19
5.2.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 C. R. Bard Inc Company Overview 20
5.3.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 Cardiojustable LLC (Inactive) Company Overview 24
5.4.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 Colorado Therapeutics, LLC Company Overview 25
5.5.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 CryoLife Inc Company Overview 26
5.6.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 DSM Biomedical BV Company Overview 27
5.7.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 27
5.8 Eqalix Inc Company Overview 28
5.8.1 Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 28
5.9 FIT Biotech Oy Company Overview 30
5.9.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 30
5.10 Gel-Del Technologies, Inc. Company Overview 32
5.10.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.11 Graftworx, LLC Company Overview 33
5.11.1 Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview 33
5.12 Healionics Corporation Company Overview 34
5.12.1 Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview 34
5.13 Humacyte Inc Company Overview 35
5.13.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 35
5.14 Innovia LLC Company Overview 39
5.14.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 39
5.15 Northwestern University Company Overview 40
5.15.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 40
5.16 NuVascular Technologies Inc Company Overview 41
5.16.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 41
5.17 PetVivo Holdings Inc Company Overview 42
5.17.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.18 RegenaGraft Company Overview 43
5.18.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 43
5.19 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 44
5.19.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 44
5.20 SurgaColl Technologies Ltd Company Overview 45
5.20.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
5.21 Universidad de Los Andes Company Overview 46
5.21.1 Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview 46
5.22 University of Louisville Company Overview 47
5.22.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 47
5.23 Vascutek Ltd Company Overview 48
5.23.1 Vascutek Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
5.24 VesselTek BioMedical LLC Company Overview 49
5.24.1 VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 49
5.25 VESSL Therapeutics Ltd Company Overview 51
5.25.1 VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
5.26 Xeltis AG Company Overview 52
5.26.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 52
6 Vascular Grafts- Recent Developments 53
6.1 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) 53
6.2 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 53
6.3 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 55
6.4 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 56
6.5 Jul 07, 2017: MPSC New COO Glendy Wang on Board 57
6.6 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 57
6.7 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 59
6.8 Apr 27, 2017: Fit Biotech: Appointments in Fit Biotech's Management 60



Comments

Post a Comment